English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52679823    在线人数 :  594
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"許駿"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 81-130 / 148 (共3页)
<< < 1 2 3 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立臺灣大學 2010 Design, Translation, and Test of Multi-Dimensional Questionnaires 季瑋珠; 許駿; 章殷超; 程劭儀; 高芷華; CHIE, WEI-CHU; HSU, CHIUN; Y.C.CHANG; CHEN, G SHAO-YI; KAO, TZE-WAH
國立臺灣大學 2010 Potentiating the Anti-Tumor Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Signaling Pathway 歐大諒; 許駿; 沈盈君; 鄭安理; OU, DA-LIANG; HSU, CHIUN; SHEN, YING-CHUN; CHENG, ANN-LII
國立臺灣大學 2009 The Aurora Kinase Inhibitor Ve-465 Has Anticancer Effects in Pre-Clinical Studies of Human Hepatocellular Carcinoma 許輝吉; 徐志宏; 葉培彥; 黃繼瑩; 郭頌鑫; 許駿; 胡賦強; 鄭永銘; 鄭安理; HSU, HEY-CHI; HSU, CHIH-HUNG; YEH, PEI-YEN; HUANG, CHI-YING; KUO, SUNG-HSIN; HSU, CHIUN; HU, FU-CHANG; JENG, YUNG-MING; CHENG, ANN-LII
國立臺灣大學 2009 Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival 沈盈君; 胡賦強; 鄭永銘; 張毓廷; 林宗哲; 章明珠; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2009 INDUCTION OF BIM EXPRESSION CONTRIBUTES TO THE ANTITUMOR SYNERGY BETWEEN SORAFENIB AND MITOGEN-ACTIVATED PROTEIN KINASE/EXTRACELLULAR SIGNAL-REGULATED KINASE KINASE INHIBITOR CI-1040 IN HEPATOCELLULAR CARCINOMA 歐大諒; 沈盈君; 梁嘉德; 劉俊陽; 俞松良; 盧彥伸; 許駿
國立臺灣大學 2009 Induction of Bim Expression Contributes to the Antitumor Synergy between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal- Regulated Kinase Kinase Inhibitor Ci-1040 in Hepatocellular Carcinoma 歐大諒; 沈盈君; 梁嘉德; 劉俊揚; 俞松良; 盧彥伸; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; LIANG, JA-DER; LIOU, JUN-YANG; YU, SUNG-LIANG; LU, YEN-SHEN; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2009 Overexpressed Focal Adhesion Kinase Predicts a Higher Incidence of Extrahepatic Metastasis and Worse Survival in Hepatocellular Carcinoma 詹以吉; 柯博升; 許駿; 王約翰; 劉俊揚; JAN, YEE-JEE; KO, BO-SHENG; HSU, CHIUN; WANG, JOHN; LIOU, JUN-YANG
國立臺灣大學 2009 A Phase Ii Study of Bevacizumab (B) and Erlotinib (E) in Combination for Asian Patients (Pts) with Advanced/Metastatic Hepatocellular Carcinoma ( Hcc): An Interim Safety Report 徐志宏; 邱宗傑; 許駿; 鄭安理; HSU, CHIH-HUNG; CHIOU, TZEON-JYE; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2009 A Phase Ii Study of Sorafenib in Combination with Tegafur/Uracil (Uft) for Asian Patients with Advanced Hepatocellular Carcinoma (Hcc) 沈盈君; 許駿; 徐志宏; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; HSU, CHIH-HUNG; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; CHENG, ANN-LII
國立臺灣大學 2009 A Phase Ii Trial of Thalidomide Plus Tegafur/Uracil for Patients with Advanced/Metastatic Hepatocellular Carcinoma (Hcc): Final Report 徐志宏; 林宗哲; 沈盈君; 許駿; 鄭安理; HSU, CHIH-HUNG; LIN, ZONG-ZHE; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2009 Adjuvant Interferon Therapy after Curative Therapy for Hepatocellular Carcinoma (Hcc): A Meta-Analysis 許駿; 沈盈君; 陳立宗; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; CHEN, LI-TZONG; HU, FU-CHANG; CHENG, ANN-LII
國立臺灣大學 2009 Evaluation of Vandetanib in Patients with Inoperable Hepatocellular Carcinoma (Hcc): A Randomized, Double-Blind, Parallel Group, Multicentre, Phase Ii Study 許駿; 謝瑞坤; 黃偉修; 趙毅; 鄭安理; HSU, CHIUN; HSIEH, RUEY-KUN; HWANG, WEI-SHOU; CHAO, YEE; CHENG, ANN-LII
國立臺灣大學 2009 Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy 林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII
國立臺灣大學 2009 Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy 許駿; 魏淑鉁; 鄭安理; 陳培哲; HSU, CHIUN; WEI, SHU-CHEN; CHENG, ANN-LII; CHEN, PEI-JER
國立臺灣大學 2009 Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway 陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2009 Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway 陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2009 Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer 葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII
國立臺灣大學 2008-07-31 肝癌之轉譯研究:探索分子標靶及治療方法-肝細胞癌之「節拍器式」化學治療藥物及抗血管新生分子靶向治療藥物之最佳化研究(子計畫六)(1/3) 許駿
國立臺灣大學 2008-06 Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新
國立臺灣大學 2008 Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome 沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2008 Comparison of Hypoplastic Myelodysplastic Syndrome (Mds) with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies 黃泰中; 柯博升; 唐季祿; 許駿; 陳建源; 蔡偉; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; 田蕙芬; HUANG, TAI-CHUNG; KO, BO-SHENG; TANG, JIH-LUH; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING- CHING; WANG, CHIU-HWA; TIEN, HWEI-FANG
國立臺灣大學 2008 A Revisit of Prophylactic Lamivudine for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma: A Randomized Trial 許駿; 熊昭; 蘇益仁; 黃偉修; 張明志; 李啟誠; 巫宏博; 田蕙芬; 趙祖怡; 鄭安理; 陳培哲; HSU, CHIUN; HSIUNG, CHAO A.; SU, IH-JEN; HWANG, WEI-SHOU; CHANG, MING-CHIH; LI, CHI-CHENG; WU, HUNG-BO; TIEN, HWEI-FANG; CHAO, TSU-YI; CHENG, ANN -LII; CHEN, PEI-JER
國立臺灣大學 2008 Expression of the Nuclear Factor Kappa B (Nfkb) P50/P65 Proteins in Hepatocellular Carcinoma (Hcc): Lack of Predictive Value for Response to Thalidomide Treatment 許駿; 陳立宗; 趙毅; 沈盈君; 鄭安理; HSU, CHIUN; CHEN, LI-TZONG; CHAO, YEE; SHEN, YING-CHUN; CHENG, ANN-LII
國立臺灣大學 2008 Forkhead Box Transcription Factor Foxo3a Suppresses Estrogen-Dependent Breast Cancer Cell Proliferation and Tumorigenesis 鄭建睿; 許駿; CHENG, CHIEN-JUI; HSU, CHIUN
國立臺灣大學 2008 Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial 許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN
國立臺灣大學 2008 Geographic Difference in Clinical Trial Practice for Advanced Hepatocellular Carcinoma (Hcc): Implications on Trial Design of Global Scale 許駿; 沈盈君; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HU, FU-CHANG; CHENG, ANN-LII
國立臺灣大學 2008 Imaging Adjustment with Dosimetric Verification of Cone-Beam Ct in Head and Neck Cancer Patient 許駿; 吳簡坤; 趙曉玲; 王駿瑋; 蔡巧琳; 成佳憲; HSU, CHIUN; WU, JIAN-KUEN; CHAO, HSIAO-LING; WANG, CHUN-WEI; TSAI, CHIAO-LING; CHENG, JASON CHIA-HSIEN
國立臺灣大學 2008 Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc) 沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII
國立臺灣大學 2008 Predictors of Toxicity of Weekly Docetaxel in Chemotherapy-Treated Non- Small Cell Lung Cancers 陳若白; 羅英; 余忠仁; 許駿; 施金元; 楊志新; CHEN, JO-PAI; LO, YIN; YU, CHONG-JEN; HSU, CHIUN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, CHIH- HSIN
國立臺灣大學 2008 Reconstructed Volume Loss on Cone-Beam Ct Images of Moving Targets 趙曉玲; 許駿; 吳簡坤; 成佳憲; CHAO, HSIAO-LING; HSU, CHIUN; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN
國立臺灣大學 2008 Weekly Cisplatin, Infusional High-Dose 5-Fluorouracil and Leucovorin for Advanced, Recurrent and Metastatic Cervical Carcinoma 蕭聖謀; 陳祈安; 許駿; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; HSU, CHIUN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG
國立臺灣大學 2008 Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2 陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2007 Comparison of Hypoplastic Myelodysplastic Syndrome with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies 田蕙芬; 柯博升; 許駿; 陳建源; 蔡偉; 唐季祿; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; TIEN, HWEI-FANG; KO, PO-SHENG; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; TANG, JIH- LUH; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING-CHING; WANG, CHIU-HWA
國立臺灣大學 2007 Dynamic Mri Signals in the Second Week of Radiotherapy Relate to Treatment Outcomes of Hepatocellular Carcinoma: A Preliminary Result 梁博欽; 常慧如; 許駿; 曾鑠鑠; 施庭芳; 劉滄梧; LIANG, PO-CHIN; CHANG, HUI-JU; HSU, CHIUN; TSENG, SHUO-SHUO; SHIH, TIFFANY TING-FANG; LIU, TSANG-WU
國立臺灣大學 2007 Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial 林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN
國立臺灣大學 2007 A Phase Ii Trial of Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Patients with Chemotherapy-Pretreated Metastatic Breast Cancer 林家齊; 鄭安理; 徐志宏; 盧彥伸; 許駿; 葉坤輝; 吳貞瑤; 黃俊升; 楊志新; LIN, CHIA-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; LU, YEN-SHEN; HSU, CHIUN; YEH, KUN-HUEI; WU, CHEN-YAO; HUANG, CHIUN-SHENG; YANG, CHIH-HSIN
國立臺灣大學 2006 PHASE I STUDY OF BIWEEKLY GEMCITABINE FOLLOWED BY OXALIPLATIN AND SIMPLIFIED 48-H INFUSION OF FLUOROURACIL/LEUCOVORIN FOR ADVANCED PANCREATIC CANCER CHANG, HUI-JU; WANG, CHUAN-CHENG; CHENG, ANN-LII; HSU, CHIUN; LU, YEN-SHEN; CHANG, MING-CHU; LIN, JAW-TOWN; WANG, HSIU-PO; LIU, TSANG-WU; CHANG, JANG-YANG; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG; 張慧如; 王全正; 鄭安理; 許駿; 盧彥伸; 章明珠; 林肇堂; 王秀伯; 劉滄梧; 張俊彥; 彭汪嘉康; 陳立宗
國立臺灣大學 2006 Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support 黃書健; 吳恩婷; 柯文哲; 賴凌平; 許駿; 張重義; 邱英世; 王水深; 吳美環; 林芳郁; 陳益祥; HUANG, SHU-CHIEN; WU, EN-TING; KO, WEN-JE; LAI, LING-PING; HSU, CHIUN; CHANG, CHUNG-I; CHIU, ING-SH; WANG, SHOEI-SHEN; WU, MEI-HWAN; LIN, FANG-YUE; CHEN, YIH-SHARNG
國立臺灣大學 2006 Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer 鄭安理; 許駿; 徐志宏; 劉滄梧; 張俊彥; 詹昌明; 趙毅; 尤維蘭; 彭汪嘉康; 陳立宗; CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; LIU, TSANG-WU; CHANG, JANG-YANG; JAN, CHANG-MING; CHAO, YEE; YU, WEI-LAN; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG
國立臺灣大學 2006 Difference in the Incidence Trend of Nasopharyngeal and Oropharyngeal Carcinomas in Taiwan: Implication from Age-Period-Cohort Analysis 許駿; 沈盈君; 洪瑞隆; 張啟仁; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HONG, RUEY-LONG; CHANG, CHEE-JEN; CHENG, ANN-LII
國立臺灣大學 2006 Survival Outcome and Predictors of Gefitinib Antitumor Activity in East Asian Chemonaive Patients with Advanced Nonsmall Cell Lung Cancer 楊志新; 施金元; 陳焜結; 余忠仁; 楊宗穎; 林京珮; 蘇文彬; 高劍虹; 許駿; 張基晟; 楊泮池; YANG, CHIH-HSIN; SHIH, JIN-YUAN; CHEN, KUN-CHIEH; YU, CHONG-JEN; YANG, TSUNG-YING; LIN, CHING-PEI; SU, WEN-PIN; GOW, CHIEN-HUNG; HSU, CHIUN; CHANG, GEE-CHEN; YANG, PAN-CHYR
國立臺灣大學 2005-06 UNEXPECTED RAPID PROGRESSION OF METASTATIC ADENOID CYSTIC CARCINOMA DURING TREATMENT WITH IMATINIB MESYLATE 顏若芳; 鄭永銘; 曾凱元; 許駿; 洪瑞隆
國立臺灣大學 2005 Significant Difference in the Trends of Female Breast Cancer Incidence between Taiwanese and Caucasian Americans: Implications from Age-Period- Cohort Analysis 沈盈君; 張啟仁; 許駿; 鄭安理; SHEN, YING-CHUN; CHANG, CHEE-JEN; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2005 Unexpected Rapid Progression of Metastatic Adenoid Cystic Carcinoma during Treatment with Imatinib Mesylate 顏若芳; 鄭永銘; 曾凱元; 許駿; 洪瑞隆; YEN, RUOH-FANG; JENG, YUNG-MING; TZEN, KAI-YUAN; HSU, CHIUN; HONG, RUEY-LONG
國立臺灣大學 2005 A Phase Ii Study Using Multi-Fractionation of Paclitaxel and Cisplatin by Twice Weekly Schedule, Plus Weekly 24-Hour Infusion of High-Dose 5- Fluorouacil and Leucovorin (Twice Weekly Tp-Hdfl) in the Treatment of Metastatic or Recurrent Esophageal Cancer: T 林家齊; 徐志宏; 葉坤輝; 許駿; 蔡育傑; 鄭安理; LIN, CHIA-CHI; HSU, CHIH-HUNG; YEH, KUN-HUEI; HSU, CHIUN; TSAI, YU-CHIEH; CHENG, ANN-LII
國立臺灣大學 2005 Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler Us and Analysis of Circulating Angiogenic Factors 許駿; 陳炯年; 謝豐舟; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; HSIEH, FON-JOU; CHENG, ANN-LII
國立臺灣大學 2005 Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials 郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR
國立臺灣大學 2005 Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer 葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII
國立臺灣大學 2005 A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer 盧彥伸; 楊志新; 許駿; LU, YEN-SHEN; YANG, CHIH-HSIN; HSU, CHIUN
國立臺灣大學 2005 Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status 蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN

显示项目 81-130 / 148 (共3页)
<< < 1 2 3 > >>
每页显示[10|25|50]项目